A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants | MicrobiomeTrials← Back to trialsNCT06947408
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2025-05-14Est. Completion: 2026-05-11
Enrollment target: 44 participants Locations- China-japan Friendship Hosipital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Asthma
The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate …
Birmingham, United StatesEst. completion Oct 31, 2026
Asthma ManagementAsthmaComputerized Decision Support SystemPrimary Care
The goal of this study is to determine whether an 'eco' version of the Electronic Asthma Management System (eAMS) can re…
Toronto, CanadaCompleted Apr 28, 2027
Chronic Rhinosinusitis With Nasal Polyps
The main objective of this study is to evaluate treatment outcomes of tezepelumab among participants with physician-dete…
Newport Beach, United StatesEst. completion Jan 13, 2027